ã¡ãã£ã¢èšäº
é«éœ¢è
ã®æ¥çš®å®äºã7ææ«ã§75%ãéŠçžãç®æšéæã
ããºãææ°ããŒã¯ 602
twitterã³ã¡ã³ã 427ä»¶äž 1ïœ100件
æ©ããªããã£ãšããéã ã£ããæµ·å€ã«æ¯ã¹ãŠããŸãé²ãã§ãããããã é«éœ¢è
ã®æ¥çš®å®äºã7ææ«ã§75ïŒ
éŠçžãç®æšéæã [æ°åã³ãããŠã€ã«ã¹] ããžã¿ã«
åœåé«éœ¢è
人å£ã®6ïŒ7å²ããããåžæè
ã ãããšèšãããŠããã®ã§75%ã¯ããããšæããããŸã åžæããé«éœ¢è
ããŸã ãŸã æãŠãŠããªãã®ã§ãç®æšéæãã§ã¯ãªãã ãããåœåã®æ³å®ãäžåã£ãããããã«ããšãã
æ¥æ¬ã¯ç«æ²æ°äž»äžå³¶å
ä»ã®ããã§æ¥çš®éå§ãé
ããã
pfizer moderna倧éæ¥çš®ã§ææ察çã¯æå
ææ¥ãææææãç œã£ãŠããæ±äº¬ã®æ»è ã»ãŒ0
ããç«æ²æ°äž» å ±ç£æ¿æš©ã ã£ããäžåœè£œã¯ã¯ãã³ããå ¥æåºæ¥ãªã
ã³ããããæ¡
ã¯ã¯ãã³ããPCR
pfizer moderna倧éæ¥çš®ã§ææ察çã¯æå
ææ¥ãææææãç œã£ãŠããæ±äº¬ã®æ»è ã»ãŒ0
ããç«æ²æ°äž» å ±ç£æ¿æš©ã ã£ããäžåœè£œã¯ã¯ãã³ããå ¥æåºæ¥ãªã
ã³ããããæ¡
ã¯ã¯ãã³ããPCR
æ¥çš®å®äºã®å®çŸ©ãã²ãšã€ã§ã¯ãªãããããåå·åºã1åã ãã§ããããšããé«éœ¢è
ãããã ããããšããããšïŒ
>äžæ¹ãæ¥çš®äºçŽã8æäžã®é«éœ¢è
ã確èªãããŠãããå®äºææã¯ã¯ã£ããããªãã
ã倧æçºã¯é ãããèªå® ã®è¿ããããããšãããã°ããæ§åèŠãããããšããé«éœ¢è ãå°ãªããªãã£ããããªã®ã§ãããã¯æ¬äººã®åžæéããšããããšã§ããã®ã§ã¯ã
ã倧æçºã¯é ãããèªå® ã®è¿ããããããšãããã°ããæ§åèŠãããããšããé«éœ¢è ãå°ãªããªãã£ããããªã®ã§ãããã¯æ¬äººã®åžæéããšããããšã§ããã®ã§ã¯ã
ãå
眪笊ããšããŠã®ç®çã¯ãããããéæïŒ
ã»å€ç°æ ªã«å¹æãªãããïŒ
ãšãããšã¯ãããªãå ±éãããŠãŸãã
ã»å¬ã«ã¯ããŸãæ¹ããŠã¯ã¯ãã³ãæããªããšãããªãããïŒ
ãšããããšã¯ãå šãå ±éãããŠããŸãããã
ã»å€ç°æ ªã«å¹æãªãããïŒ
ãšãããšã¯ãããªãå ±éãããŠãŸãã
ã»å¬ã«ã¯ããŸãæ¹ããŠã¯ã¯ãã³ãæããªããšãããªãããïŒ
ãšããããšã¯ãå šãå ±éãããŠããŸãããã
ãæŠãé
åžå®äºãã®ãŸãŸã«ãªã£ãŠããã¢ãããã¹ã¯é
åžã«äŒŒãŠããã
ãæ¿åºã¯ãæ¥çš®å®äºãã®å®çŸ©ã«ã€ããŠãæ°èŠã®äºçŽãå ¥ããªããªã£ããšããïŒå®éžå¹¹éšïŒãšèª¬æãããäžæ¹ãæ¥çš®äºçŽã8æäžã®é«éœ¢è ã確èªãããŠãããå®äºææã¯ã¯ã£ããããªãã
ãæ¿åºã¯ãæ¥çš®å®äºãã®å®çŸ©ã«ã€ããŠãæ°èŠã®äºçŽãå ¥ããªããªã£ããšããïŒå®éžå¹¹éšïŒãšèª¬æãããäžæ¹ãæ¥çš®äºçŽã8æäžã®é«éœ¢è ã確èªãããŠãããå®äºææã¯ã¯ã£ããããªãã
ã ãããã®åœã§äžå²ããå
«å²ã§é æã¡ã ãšããããé«éœ¢è
ã®æ¥çš®ã¯ãããªãã®ããšãããšããã
次ã¯æã ã®çªã ã
次ã¯æã ã®çªã ã
ãããè
矩åãç®æšãææ§ã«ããŠãç²æããããŸããã! ãããã!
ã©ããªã«ã¯ã¯ãã³åŸ
ã¡ã䞊ãã§ãŠãéæ宣èšããã°éæããäºã«ãªãã®ã¯åãã£ãŠãã
ææ¥æ°èããžã¿ã«
ãç®æšéæããšèšã£ãŠãããã©ããã¯ãšããããããèªäœã¯è©äŸ¡ããŠããã¯ããç±³åœã§ãããã®æ°Žæºã«å°éãããŸã§ã«ã¯ïŒãæ以äžããã£ããšæãã
ïœ
ïœ
æ¥çš®ããŠããªãé«éœ¢è
ãçŽ7人ã«1人ããã®æ±ºæã«è³ã£ãèæ¯ã«äœãããã®ãåæããŠã»ããã
éŠçžãç®æšéæã
èªåãã¡ãšå¯è£å±€ã®å©æš©å£äœã«ã¯æã¡çµãã£ããã庶æ°ãã©ããªãããšç¥ã£ãããšã§ã¯ãªããšã§ãæã£ãŠããã ããã
èªåãã¡ãšå¯è£å±€ã®å©æš©å£äœã«ã¯æã¡çµãã£ããã庶æ°ãã©ããªãããšç¥ã£ãããšã§ã¯ãªããšã§ãæã£ãŠããã ããã
ã¯ã¯ãã³ç¡ãã®ã«ã©ããã£ãŠéæãããã ãã
ã64æ³ä»¥äžã®æ¥çš®çã¯äœãæ°Žæºã«ãšã©ãŸããéŠçžå®éžã®HPã«ãããšã8æ1æ¥æç¹ã§1åç®ãçµããã®ã¯å
šäººå£ã§ã¯çŽ34ã»5%ã«ãããçŽ4382äžäººã2åç®ãŸã§çµããã®ã¯çŽ24ã»6%ã®çŽ3126äžäººããæ¥çš®çäœããŸãŸå¬ã«çªå
¥ããã®ããŒâŠïŒçµ¶æïŒã
ãæ¿åºã¯ãæ¥çš®å®äºãã®å®çŸ©ã«ã€ããŠãæ°èŠã®äºçŽãå
¥ããªããªã£ããšããïŒå®éžå¹¹éšïŒãšèª¬æããæ¥çš®äºçŽã8æäžã®é«éœ¢è
ã確èªãããŠãããå®äºææã¯ã¯ã£ããããªããããå®äºãã®å®çŸ©ãã¶ã£å£ããâ
æ¿åºç®æšãã幟åæ©ãããŒã¹ã§æ¥çš®ãé²ãã§ãããéå
ãèè
ãšåŒã°ãã人éã¯ãäžå¯èœãšèšã£ãŠããããæŠãå®çŸããã®ã¯è©äŸ¡ãã¹ãå®çžŸã§ã¯ïŒæ¿åº
è
矩åãé«éœ¢è
ã®ã¯ã¯ãã³æ¥çš®ãå
šå¡çµäºãããåãã ãã
ããã¯åã ãåžæè å šå¡ãç®æšã ããæ¿åºã«ãã®ãå®çŸ©ããªãã65æ³ä»¥äžã§8æã«äºçŽããŠã人ããããåžæããŠãããŸã äºçŽããŠãªã人ãããªããšããªãèšããã®ãïŒ
ããã¯åã ãåžæè å šå¡ãç®æšã ããæ¿åºã«ãã®ãå®çŸ©ããªãã65æ³ä»¥äžã§8æã«äºçŽããŠã人ããããåžæããŠãããŸã äºçŽããŠãªã人ãããªããšããªãèšããã®ãïŒ
ïŒ"éŠçžã4æ23æ¥ã®èšè
äŒèŠã§ããåžæããé«éœ¢è
ã«7ææ«ã念é ã«åèªæ²»äœã2åã®æ¥çš®ãçµããããšãã§ãããããæ¿åºãæããŠåãçµãããšè¡šæããŠããã"
ææãšããŠã¯åãããéæããããšèšããšããŠãªãããããŠãªãã§ãããè
ããèšèéžã³ãäžæããã ãã
ç®æšã®å®çŸ©ãææ§ãªã®ã«ãç®æšéæã£ãŠèšã£ãŠããªãã
çã奎ã®è©±ãèããŠããããªæããããªãã
諞説ãããã ãããã©80%ã®éå£å ç«ç²åŸã£ãŠèšãç®å®ããã£ãããããªãã£ãã£ãïŒ
çã奎ã®è©±ãèããŠããããªæããããªãã
諞説ãããã ãããã©80%ã®éå£å ç«ç²åŸã£ãŠèšãç®å®ããã£ãããããªãã£ãã£ãïŒ
ç®æšéæãšã¯ãµããã話ã ãããã64æ³ä»¥äžã¯8æäžæ¬ã«2åç®æåã£ãŠããªã¬ã1åç®ã®äºçŽåããã®9æã ããèããŠãã®ããã±ã
ç®æšéæãŠããð
ãããªã®åã§ããç§ã®è¿æã®æ¹ã¯ãŸã ããã£ãŠãªããã§ããïŒããã6人ã
ãããªããšããã65æ³æªæºã®ã¯ã¯ãã³æ¥çš®ã¯ãã©ããªã£ãŠãã®ïŒ
è©Šåã®åºŠã«ãŽãŒã«ãåããããåŠãè¶çªïŒã«ãŒã«ç¡ãåŠèšããããªäºã§å¹æçãªå¯Ÿççåºæ¥ãã®ã ãããïŒééã£ãŠãããæ€èšŒããŠãæ°ããªå¯Ÿçãç«ãŠãã®ã察çã®åºæ¬ã ãïŒ
ãã«ã¿æ ªã¯ãã¯ã¯ãã³ã¯ç¹ã«é«éœ¢è
ã«ã¯å¹æããªããšã¢ã¡ãªã«ãå ±åããŠããã®ã«ãããŸãããèªæ
¢ã«ããªããªãã
ãç®æšéæããšã¯ãããåžæè
ãã©ãã ããããåãããªãã
ã£ãŠãã©ããªã¬ãã«ã®ç®æšãæ±ããŠããããæ¹å€ãããã®ææ¥ïŒ
ã£ãŠãã©ããªã¬ãã«ã®ç®æšãæ±ããŠããããæ¹å€ãããã®ææ¥ïŒ
ããããã³ããªãã
é«éœ¢è ã¯ãŽããŽãæ»ã«å§ããã
ããããŠãœãªãã
æŽãªãæ¯ã¯ã¯ãã³æ¥çš®ãä¿ãèšç»ã ããã
ã©ã®ã¿ã¡äœäžã€å¬ãããªãææªãªãã¥ãŒã¹ã ãã
é«éœ¢è ã¯ãŽããŽãæ»ã«å§ããã
ããããŠãœãªãã
æŽãªãæ¯ã¯ã¯ãã³æ¥çš®ãä¿ãèšç»ã ããã
ã©ã®ã¿ã¡äœäžã€å¬ãããªãææªãªãã¥ãŒã¹ã ãã
ç¡çã ç¡çã èšã£ãŠã人å€ãã£ããã©ããããŸã§ãããã ã
4人ã«3人
ããšããšæ°åã§ç®¡çããŠããªãããããªããšã§ãèšãããªã
ããšããšæ°åã§ç®¡çããŠããªãããããªããšã§ãèšãããªã
æãããŠä¿¡çšã§ããã®ããªïŒç§ã®äœãã§ããèªæ²»äœã§ã¯ïŒïŒæ³ä»¥äžã®äººã®æ¥çš®äºçŽã®ïŒåç®ãå§ãŸã£ãã°ããã§ãã
ãªãããã³ããã«é¢ããŠã¯æ¿åºã®èª¬æã¯ä¿¡çšã§ããªãã
ãªãããã³ããã«é¢ããŠã¯æ¿åºã®èª¬æã¯ä¿¡çšã§ããªãã
è£éåŽåå¶ããŒã¿ãæé ããååŽçãçºè¡šããæ°åã§ããçã«ããã€ããŠèããŸãããã
ãã£ã±ãäžå¯èœã ã£ãð¡ð¡ð¡
7ææ«ãšããã®ã¯ãªãªã³ããã¯ã念é ã«çœ®ããç®æšã ã£ãã®ã§ã¯ãªãããšæãããçŸæç¹ã§åžæããŠããã®ã«ãŸã æãŠãŠããªãé«éœ¢è
ããããªããããéæãšåŒã¶ã®ã¯å²æ
¢
ã§ãæ¬åœã¯äœ%ãªãã§ããïŒ
ã³ã¬ã§æºè¶³ãªã®ãïŒãªã«ã倧äºãªã®ã解ã£ãŠãïŒ
æ¥ææ¥ã«è²·ãç©ã«ã§ãããŠèžååŸ
ã¡ã§ãªãããããŒãªãšæã£ããåã«ãããã£ãªã«ä¹ã£ãçºãããŒãã¹ã¯ã¿ãã³ãã¡ãŠãŠããã€ããã¶ãã¯ã¯ãã³çµãã£ãŠãã ãããªããšæãã€ã€ãšããããæ»ããç³çºãšããçµè«ã«éããã
ãã®çŸç¶ã§ãããïŒ
ãªã®ã«ãªãªã³ããã¯ç¶ç¶ã銬鹿ãªãã§ããïŒ
å°æ± ãã
ãªã®ã«ãªãªã³ããã¯ç¶ç¶ã銬鹿ãªãã§ããïŒ
å°æ± ãã
åž°çã¯åŸ1幎ã§è¯ãããææ
¢ããŠæ¬²ãã ãªã¢ã«ã¿ã€ã åç»ã§ãããšãããæ¹æ³äº€éè²»ã®ä»£ããã«æŽåããŠãããããã° å°çšç«¯æ«ã§å°ãªããã¿ã³ã§
æ¥æ¬ã¯ç«æ²æ°äž»äžå³¶å
ä»ã®ããã§æ¥çš®éå§ãé
ããã
pfizer moderna倧éæ¥çš®ã§ææ察çã¯æå
ææ¥ãææææãç œã£ãŠããæ±äº¬ã®æ»è ã»ãŒ0
ããç«æ²æ°äž» å ±ç£æ¿æš©ã ã£ããäžåœè£œã¯ã¯ãã³ããå ¥æåºæ¥ãªã
ã³ããããæ¡
ã¯ã¯ãã³ããPCR
pfizer moderna倧éæ¥çš®ã§ææ察çã¯æå
ææ¥ãææææãç œã£ãŠããæ±äº¬ã®æ»è ã»ãŒ0
ããç«æ²æ°äž» å ±ç£æ¿æš©ã ã£ããäžåœè£œã¯ã¯ãã³ããå ¥æåºæ¥ãªã
ã³ããããæ¡
ã¯ã¯ãã³ããPCR
ãè害ããšãå¿ç¡ãèšèã䜿ã人ããããã©ãç§ã¯ãããã¡ããã»ãã°ãã¡ããã®ã¡ãã£ãšããã£ãããªæãã人çå²åŠãªãããèŽãã®å€§å¥œãã§ãã
æ¿åºã¯é«éœ¢è ãåãæšãŠã«ããã£ãŠããã©ãé«éœ¢è ã®æ¹ãã¡ã¯ä»åŸãçµ¶å¯Ÿå¿ èŠã
çãæ®ã£ãŠæ¬²ããã§ãã
æ¿åºã¯é«éœ¢è ãåãæšãŠã«ããã£ãŠããã©ãé«éœ¢è ã®æ¹ãã¡ã¯ä»åŸãçµ¶å¯Ÿå¿ èŠã
çãæ®ã£ãŠæ¬²ããã§ãã
æ°åã®çœ
âæ¿åºã¯ã7ææ«ãŸã§ã«åžæããå šãŠã®é«éœ¢è ãžã®æ¥çš®å®äºãç®æšã«æ²ããŠãããïŒäžç¥ïŒãã ãã©ã®ãããã®äººãæ¥çš®ãåžæããŠãããã¯äžæã§ãâ
âæ¿åºã¯ã7ææ«ãŸã§ã«åžæããå šãŠã®é«éœ¢è ãžã®æ¥çš®å®äºãç®æšã«æ²ããŠãããïŒäžç¥ïŒãã ãã©ã®ãããã®äººãæ¥çš®ãåžæããŠãããã¯äžæã§ãâ
éŠçžãã7ææ«ãã£ãŠç®æšãæ²ãããšãã¯ã»ãŒå
šå¡ããç¡çç¡çç¡çãã£ãŠèšã£ãŠããã ãããVRSã«æå
¥ãããã®ã«ã©ã°ãããããšãèããã°ããã®çµæã¯çŽ çŽã«è©äŸ¡ãã¹ãã ãšæã
ç¹ã«çŸå Žã®çæ§ã«æè¬
ç¹ã«çŸå Žã®çæ§ã«æè¬
ïŒè¥ãäžä»£ã«ãèšãåã§ããïŒ
çŸåœ¹ã®
äžä»£ã®åã
ãªãã¯ãã âŠ
çŸåœ¹ã®
äžä»£ã®åã
ãªãã¯ãã âŠ
7/29 ææ¥å ±é
ïŒåæã®åæããè©Šç®ãããšãå°ãªããšã人å£ã®6ïœ7å²ã®æ¥çš®çãå¿ èŠ
ïŒå°Ÿèº«æ°ã¯ãçŽé¢ããŠãããã«ã¿æ ªã®ææåã匷ãã
8/2
ã人å£70ïŒ ä»¥äžããšç°ãªãã75ïŒ ã¯ãããããŠç®æšéæãšè§£éã§ãããããããŸãã
ïŒåæã®åæããè©Šç®ãããšãå°ãªããšã人å£ã®6ïœ7å²ã®æ¥çš®çãå¿ èŠ
ïŒå°Ÿèº«æ°ã¯ãçŽé¢ããŠãããã«ã¿æ ªã®ææåã匷ãã
8/2
ã人å£70ïŒ ä»¥äžããšç°ãªãã75ïŒ ã¯ãããããŠç®æšéæãšè§£éã§ãããããããŸãã
2åç®çµäºã75%ã§1åç®ã86%ãªãã°ãåžæããŠããé«éœ¢è
ã¯86ïŒ
ã§ã11ïŒ
ãªäººãéã«åã£ãŠãªããšããããšããã®æç¹ã§ç®æšäžéæã ãããããç¡çç¢çéæã«ããŠèª€éåãããšããã®ã極ããŠæµ
ã¯ãã
é«éœ¢è
ã®ïŒåç®æ¥çš®ã75ïŒ
ãæžãã°ã倧æåã ãšæããŸããã
ããããã¯ãæŠç¥ãå€æŽããŠéäžçã« ã§æ¥çš®ããã®ãè¯ããæ±äº¬éœã¯å
šåœã® åããŠããŠãæ±äº¬ã®é®ç«ããªããã°å
šåœã®æ¶ç«ãäžå¯èœã ã
ããããã®æåããKPIã®æž¬å®æ¹æ³ãããåãããŠããããšæããç®æšèšå®ã®åºæ¬ãªã®ã«ã
5æ30æ¥æç¹ã§ç°æåççžã¯ã7æ«ãŸã§ã«é«éœ¢è
æ¥çš®å®äºããšä»°ã£ãŠãŸããã75ïŒ
ã§ãªããç®æšéæããªã®ã§ããïŒ
é«éœ¢è
ã«ãããã¯ã¯ãã³æ¥çš®åžæè
æ°ãäžæãªã®ã«ç®æšéæã£ãŠããžã§æå³ãããããªã
é«éœ¢è
ã®æ¥çš®å®äº7ææ«ã§75% éŠçžãç®æšéæãã£ãŠããã®æ¿æ²»å®¶ãã¡å¿åºè¥è
ã¯ã©ãã§ãããã®ããèŠããã§ãã
ãªãã§ãã£ãŠïŒ
éžæã«æ¥ãªãããã ã
éžæã«è¡ããªãïŒä»ã®æ¿æ²»OKïŒããããªå åïŒã£ãŠèšã£ãŠãã®ãšåãããšã ããã
倧äºã«ããããããªãããã
ãªãã§ãã£ãŠïŒ
éžæã«æ¥ãªãããã ã
éžæã«è¡ããªãïŒä»ã®æ¿æ²»OKïŒããããªå åïŒã£ãŠèšã£ãŠãã®ãšåãããšã ããã
倧äºã«ããããããªãããã
ãŠãœããéé
ãŸã é«éœ¢è
ã ãã§ããã ãïŒ
åžäžãå»çé£æ°ã§æº¢ããŠãç®æšéæãããšèžã匵ãè
éŠçžã«ã¯ã€ã€â
ãŸã éœåã®è¯ãããã«æ¥çš®å®äºãå®çŸ©ããã®ãããã€ããã€ããããªã®ã°ã£ããã
ã¬ãŒã¹ãŒèªå·±æºè¶³ð
ã1åç®æ¥çš®çïŒ2åç®æ¥çš®çïŒ10%ãã®å·®ãæãã
350äžäººã2åç®ãããŠãªãã®ãâïž
ã¹ã¬ããå šåžæè éæãã®æ ¹æ ã瀺ãâŒïžð
ã¿ã¯ã±ã¬ãŒã¹ãŒð
ã1åç®æ¥çš®çïŒ2åç®æ¥çš®çïŒ10%ãã®å·®ãæãã
350äžäººã2åç®ãããŠãªãã®ãâïž
ã¹ã¬ããå šåžæè éæãã®æ ¹æ ã瀺ãâŒïžð
ã¿ã¯ã±ã¬ãŒã¹ãŒð
1åç®86.2%ã2åç®75.5%ãªã倧æåã®éšé¡ã ãªãã¯ã¯ãã³é¢ä¿ã¯ãããã£ãšãã
ãŸãè
矩åãåãã§ãã§ããšãã¡ãªã¿ã«æå¹ãšå®€èã¯é«éœ¢è
ã®2åç®ã¯ã¯ã¯ãã³ã®äŸçµŠäžè¶³ã«äŒŽã5å²ã ãããªã«ãç®æšéæãããããããã«ãããïŒ
ã§ïŒ
éçå察çã«ã¯ãªã£ãŠãææ察çã«ãªããªãã®ã¯ãä»ã®ç¶æ³ãšæµ·å€ã®ãã¥ãŒã¹ã§ãããããïŒ
ããããäœããŠãããã®ãããïŒð
éçå察çã«ã¯ãªã£ãŠãææ察çã«ãªããªãã®ã¯ãä»ã®ç¶æ³ãšæµ·å€ã®ãã¥ãŒã¹ã§ãããããïŒ
ããããäœããŠãããã®ãããïŒð
1åç®86%è¶
ãã£ãŠåããªã2åç®ãããªãéžæè¢åã人ãªããŠ0.1%ãããªãã ãããã
çŽ çŽã«çŽ æŽãããæ°åã ãšæãã
çŽ çŽã«çŽ æŽãããæ°åã ãšæãã
ããã£ãœãæ°ãããã
è¡é¢éžåã ãããªãããã
è¡é¢éžåã ãããªãããã
â65æ³ä»¥äžã®é«éœ¢è
åãïŒå¯Ÿè±¡è
çŽ3549äžäººïŒã®æ°åã³ãããŠã€ã«ã¹ã®ã¯ã¯ãã³æ¥çš®ãã7æ31æ¥ã®æç¹ã§1åç®ãçŽ86ã»2%ã2åç®ãçŽ75ã»5%ã«éããããšãå
é£å®æ¿ã®éèšã§åãã£ããâ
ç®æšæªéæ
æåã«ãã¡ããšåºæºãšãªãæ°åãäžããåæã«çµè«ã¥ããã®ã§ãã¡ã§ããããçŽã
ãã¯ããŽãŒã«ãã¹ãåããããªãã
åã€ãéŠçžãåéããã®äœã§ããªïŒã£ãŠæã£ãã
æ°åãããã«èŠããªããèšç®ãåºæ¥ãªãããã ã£ã
ããã ããã£ããšèŸããè害ãã³ã±ãŒãïŒ
æ°åãããã«èŠããªããèšç®ãåºæ¥ãªãããã ã£ã
ããã ããã£ããšèŸããè害ãã³ã±ãŒãïŒ
âæ¿åºã¯ã7ææ«ãŸã§ã«åžæããå
šãŠã®é«éœ¢è
ãžã®æ¥çš®å®äºãç®æšã«æ²ããŠããâ
âã©ã®ãããã®äººãæ¥çš®ãåžæããŠãããã¯äžæâ
âã©ã®ãããã®äººãæ¥çš®ãåžæããŠãããã¯äžæâ
ç®æšéæåºæ¥ãŠãªããŠè
æ¥æ¬ã®éŠçžã®èªç»èªè³ãé
·ããã
ã2åç®ã®æ¥çš®çã¯å
šéœéåºçã§67%以äžã
èŠåºããšãã®æ°ã®å·®ãããããªãã誰ãæããŠãã
èŠåºããšãã®æ°ã®å·®ãããããªãã誰ãæããŠãã
ã8æäžæ¬ã«2åã®æ¥çš®ãçµããå²åãå
šãŠã®åœæ°ã®4å²ãè¶
ããããåãçµãã
ä»ã®ãã«ã¿æ ªã®å¢ãã ãšãæ¥çš®ããåã«ææãã人ãçžåœæ°ã«äžãããã ã
ä»ã®ãã«ã¿æ ªã®å¢ãã ãšãæ¥çš®ããåã«ææãã人ãçžåœæ°ã«äžãããã ã
ãŸãããããªäºãããã ããâŠ
åœæžãã§é 匵ã£ãŠãããå»çåŸäºè
ã®ææã暪åãããè
ç·çã
èªæ°å ã¯åœæ°ã®åœãããã«ãã
å»çåŸäºè ã«ã¯äœã®æè¬ãããŠããªãã
ä»ã®æ¥æ¬ã®ç¶æ³ãèŠãã°äžç®çç¶ã
èªæ°å ã¯åœæ°ã®åœãããã«ãã
å»çåŸäºè ã«ã¯äœã®æè¬ãããŠããªãã
ä»ã®æ¥æ¬ã®ç¶æ³ãèŠãã°äžç®çç¶ã
èªæ°å
ãç²ç®çã«æ¯æãã祚ç°ã¯OKã ãïŒ
ã¯ã¯ãã³æ¥çš®ããŠãããã«ã¿æ ªã«ã¯å¹ããªãã
ããã§ã
è
éŠçžã¯ãïŒææ«ã念é ã«ãåžæããå
šãŠã®é«éœ¢è
ã«ïŒåã®æ¥çš®ãçµããããããšèšã£ãŠããããæ¥çš®äºçŽã8æäžã®é«éœ¢è
ã確èªããããŠããã®ã«ããç®æšãéæããããšãã§ããããšã¯ïŒ
Yahooã®å€§æ¬å¶çºè¡šã£ãœã
ãã宣èšæ £ããå€æ¥œãã人ã 倧éªã
èªå£²
ããã³ã¢ã«ã§ã åžžé£ã«åœè£ é Œãåºã
æ¯æ¥
ã ææ¥
ãéœã®èªç²çäžæåŸå äºèŒªåœ±é¿ãã
èªå£²
ãã宣èšæ £ããå€æ¥œãã人ã 倧éªã
èªå£²
ããã³ã¢ã«ã§ã åžžé£ã«åœè£ é Œãåºã
æ¯æ¥
ã ææ¥
ãéœã®èªç²çäžæåŸå äºèŒªåœ±é¿ãã
èªå£²
ç®æš=éæåæã§è§£éããã¬ãããšã«æ
£ããŠããããçµæã¯è¶
é 調ãªã®ã«ãåžæããå
šãŠã®é«éœ¢è
ã®æ¥çš®ãšããç®æšéæãâã8æã«æ¥çš®äºçŽããé«éœ¢è
ãããšããããã³ãã®äœå°ãçãŸãã¡ãããã ãšæãããã£ãããªãã
ææ¥æ°èãšããããã« ãã¹ãªãŒããæãã¿ã€ãã«
æäžã7æ31æ¥ã®æç¹ã§1åç®ãçŽ86ã»2%ã2åç®ãçŽ75ã»5%ã
10.7%ïŒ300äžäººçšïŒãæ¥çš®éäžãªã®ã«æ¥çš®å®äºãšèšããèš³ç¡ããéäžã®äººã®çç±ãã¹ã¯ãªãŒãã³ã°ããŠãåžæããã®ã«åããããªã人ãè¯ãåãããªã人ãç¡ããã
æäžã7æ31æ¥ã®æç¹ã§1åç®ãçŽ86ã»2%ã2åç®ãçŽ75ã»5%ã
10.7%ïŒ300äžäººçšïŒãæ¥çš®éäžãªã®ã«æ¥çš®å®äºãšèšããèš³ç¡ããéäžã®äººã®çç±ãã¹ã¯ãªãŒãã³ã°ããŠãåžæããã®ã«åããããªã人ãè¯ãåãããªã人ãç¡ããã
VRSã®å ±åé
ããèããã°å®éã®æ¥çš®çã¯ããå°ãé«ãã¯ãã ããããã¯çŽ çŽã«è¯ãã£ãããã¬ãŒã¯ã¹ã«ãŒææã¯äžéšã«ããã«ãããå¹æãåºãŠããã
俺ãã«ãŒã«ããã¯ã ãâ(ÂŽÐŽïœ)âïŸïŸïŸïŸ
ä»ãå€åºå
ã§æã£ããã ãã©é«éœ¢è
ã®ããŒãã¹ã¯å§¿ãå¢ããŠãŸããã
ã¯ã¯ãã³æ¥çš®ãããã倧äžå€«çãªäºãªãã§ãããããææã¯ããã£ãŠäºããã£ããèªèããŠæ¬²ãããéå£ææã®äžå ã«ãªããããªãã
ã¯ã¯ãã³æ¥çš®ãããã倧äžå€«çãªäºãªãã§ãããããææã¯ããã£ãŠäºããã£ããèªèããŠæ¬²ãããéå£ææã®äžå ã«ãªããããªãã
ãã¡ã®äž¡èŠªïŒ70æ³ïŒãããããããããïŒåç®ãªãã ãã©âŠå¥ã«ã¯ã¯ãã³ãå¿é¿ããŠããèš³ã§ã¯ãªãã®ã ããã©âŠ
ïŒ
ïŒ
ã¢ãããã¯ã¯ãã³ã¯æ²»çè¬ã§ãªããããŸã§ãéçå察çã«éããªããäœèªæ
¢ããŠãïŒ
æ
é·ã®å°åã¯1åç®ããæãŠãŠãªãé«éœ¢è
ã倧éšåã ãã©ãéŠçžã®ç®ã«ããããéçå°åã¯å
¥ã£ãŠãªããã ããããå
šåœã§ã®ããŒã»ã³ããŒãžã§ã¯äººå£ã®å°ãªãå°åã¯èª€å·®ã«ãªã£ã¡ããããã
ã¯ã¯ãã³æ¥çš®ã¯èªæ²»äœã®ææð
æµ·å€ã«æ¯ã¹å§åçã«é ããã®ã¯ãç¡çã¬ãŒã¹ãŒæ¿æš©ã®å€§å€±æ ð€·ð±ð€¬ã¬ãŒã¹ãŒãæ³åŸã§è£ãã¹ãð€·ð€¬
æµ·å€ã«æ¯ã¹å§åçã«é ããã®ã¯ãç¡çã¬ãŒã¹ãŒæ¿æš©ã®å€§å€±æ ð€·ð±ð€¬ã¬ãŒã¹ãŒãæ³åŸã§è£ãã¹ãð€·ð€¬
ããã§ç¥šãåå®ã§ããã»ã»ã»ãšãæã£ãŠããã®ã ããã
èšã£ãããåã¡ç¶æ
ð
説åŸåãŒãã
説åŸåãŒãã
éæããŠãããããåžæããé«éœ¢è
å
šå¡ã« 7 ææ«ãŸã§ã«æ¥çš®ãçµããããç®æšãšèšã£ãã ããããã£ãšå€ããŠããããããã â
ç®æšéæãšèšãããšããç®æšããã£ãšãã
ãåžæããå
šãŠã®é«éœ¢è
ãžã®æ¥çš®å®äºãç®æšã«æ²ããŠãããé«éœ¢è
ã®æ¥çš®ç¶æ³ã«ã€ããŠãè
矩åéŠçžã¯7æ30æ¥ã®èšè
äŒèŠã§ãç®æšãéæããããšãã§ããããšèªã£ãã
4人ã«ïŒäººã®é«éœ¢è ãæ¥çš®åžæããŠãªããšããæ ¹æ ã¯äœã ããïŒ
4人ã«ïŒäººã®é«éœ¢è ãæ¥çš®åžæããŠãªããšããæ ¹æ ã¯äœã ããïŒ
ãã§ããããããã¯ã§ããŠãããšæã£ãŠããŸããã
ãªã¡ãŒããšãã®ç·ç倧è£ãçæµ·çã«äžæ¹çåå©å®£èšããå¯æµ·çã¿ããã ãªïŒ
äžåç®æ¥çš®ããŠäºåç®ãæã£ãŠããªã人ããããã ãããè
æ°ã¯æããã«åãèšã£ãŠãããåã€ãã ã
ã»ããïœïœïœ
æ¥æ¬ãã§ããããã«ã¯ããçµããw
æ¥æ¬ã®è¬ã¯ã³ããã«å¹æçãªè¬ããWHOã¯èªããŠãããªããã ãäžççå©æš©ããæ¥æ¬ã¯ãããããŠããŸã£ãŠã説w
æ¥æ¬ãã§ããããã«ã¯ããçµããw
æ¥æ¬ã®è¬ã¯ã³ããã«å¹æçãªè¬ããWHOã¯èªããŠãããªããã ãäžççå©æš©ããæ¥æ¬ã¯ãããããŠããŸã£ãŠã説w
å㞠次ãž
ïŒåç®æ¥çš®43.8%
ïŒåç®æ¥çš®30.5%
ãšã®æ°åãåºããŠãã
ãã ããã ãç¡èŠããŠ1åç®æ¥çš®34.5%ãšãæžããŠãããã ãªã
å®éžã ã䜿ã£ãŠãã ã¡ã«åè«ããããªãã®ããããã